NCT05768425Active, not recruiting
DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia
DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia - DISPLAY
Source: ClinicalTrials.gov · Last updated 10 Oct 2023
Brief summary (registry, in English)
This a study to improve diagnosis of dementia with Lewy bodies with RT-QuIC in different biospecimens.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 55 (estimated)
- First submitted
- 13 Feb 2023
- Start date
- 1 Feb 2023
- Primary completion date
- Dec 2032
- Lead sponsor
- Danish Dementia Research Centre
- Diseases
- Lewy body dementia, Alzheimer disease
- NCT number
- NCT05768425
What you commit to
- Study type: Observational
- Planned participants: 55
- From 1 Feb 2023 to the primary completion date, Dec 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current alcohol or drug abuse
- Current alcohol or drug abuse
Other illness
- Signs of neurological/psychiatric conditions
- Known genetic neurodegenerative disease in close family
- Terminal illness
- Diagnosed with major neurological/psychiatric conditions other than DLB.
- Terminal illness
- Diagnosed with major neurological/psychiatric conditions other than AD.
Other
- Patients not able to give informed consent.
- Patients not able to give consent.
Who the study is looking for
- Age 18 - 40 years of age
- Able to cooperate as evaluated by the primary investigator (PI)
- Able to give informed consent
- Probable DLB (McKeith et al., 2017) or MCI-LB (McKeith et al., 2020)
- Age \> 50 years of age
- Able to give informed consent
- Able to cooperate as evaluated by the PI
- MCI, mild or moderate dementia, and MMSE \> 18
- Probable AD (McKhann et al., 2011) or MCI-AD (Albert et al., 2011)
- Age \> 50 years of age
- Able to give informed consent
- Able to cooperate as evaluated by the PI
- MCI, mild or moderate dementia, and MMSE \> 18
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Danish Dementia Research Centre Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.